Name: Analysis: The Trump Health Care Policies That Deserve to Stick Around
Brand: khn.org
SKU: khn-org-1152
Availability: OnlineOnly

critic

Analysis: The Trump Health Care Policies That Deserve to Stick Around

preview

March 16, 2021President Joe Biden’s goal of providing health care for more Americans advanced this week with his of an economic stimulus package that subsidies for health insurance premiums and new incentives for states to expand Medicaid, as well as the potential confirmation of Xavier Becerra as secretary of Health and Human Services.But as the current administration works to reverse the actions of its predecessor, it should recognize that former President Donald Trump introduced policies on medical care and drug price transparency that are worth preserving. Those measures could help struggling patient-consumers while the new administration pushes for the far more ambitious reforms Biden campaigned on, which include a public health insurance option and a system that would allow Medicare to negotiate drug prices.To be clear, the Trump administration, generally, put the health care of many Americans in jeopardy: It spent four years trying to overturn the Affordable Care Act, despite that law’s undeniable successes, and when repeal proved impossible, kneecapped the program in countless ways. As a result of those policies, lost health insurance during Trump’s first three years. And that’s before millions more people lost their jobs and accompanying insurance during the early days of the covid-19 pandemic.But the Trump administration did attempt to rein in some of the most egregious pricing in the health care industry. For example, it most hospitals to post lists of their standard prices for supplies, drugs, tests and procedures. Providers had long resisted calls for such pricing transparency, arguing that this was a burden, and that since insurers negotiated and , those list prices didn’t matter.Of course, prices do matter to the patients who are uninsured or end up at an out-of-network hospital when illness strikes and full freight, or nearly so. Some patients, facing bills of hundreds of thousands of dollars, have been or forced into .In 2019, the Trump administration that hospitals disclose the discounted rates that they agree to accept from insurers for common medical services, as well as prices for patients who pay in cash. To be clear, this type of transparency doesn’t directly lower bills, but the information can help patients shop around for medical care.These master price lists span hundreds of pages and are . Nonetheless, they give consumers a basis to fight back against outrageous charges in a system where a knee replacement can cost $15,000 or $75,000, . And the requirement might just motivate some providers to lower their prices, if only to compete with neighboring hospitals., hospitals said it was too hard to comply with the new rule while they were dealing with the pandemic. They still managed to continue the appeal of their lawsuit against the measure, which . The rule took effect, but the penalty for not complying is just $300 a day — a pittance for hospitals — and there is no meaningful mechanism for active enforcement. The hospitals the Biden administration to revise the requirement.Trump also used his bully pulpit to take on drug prices, remarking at his first news conference as president-elect that pharmaceutical manufacturers were “” His administration ordered drugmakers to for medications that cost more than $35 per month. (Some of the most commonly advertised drugs .) Just before the order took effect, a .Then, last summer, Trump issued aimed at forcing drug price reductions. In September his health secretary, Alex Azar, certified that importing prescription medicine from Canada “” and would result in “a significant reduction in the cost.” This statement, which previous health secretaries had declined to make, formally opened the door to importing medication. , meanwhile, now illegally purchase prescription drugs from abroad because they cannot afford to buy them at home.In Congress, bills allowing prescription have gained , but without the go-ahead from the Department of Health and Human Services, they were nonstarters. Now are moving ahead with efforts to import drugs from Canada.Biden the legalization of importing drugs during his presidential campaign. Becerra, Azar’s potential successor, voted for an importation bill in 2003 .But the drug lobby will no doubt prove a big obstacle: The Pharmaceutical Research and Manufacturers of America, an industry trade group, in November to stop the drug-purchasing initiatives. The industry has long argued that importation from even Canada would risk American lives.Finally, shortly before the election, Trump issued paving the way for a “” system that would ensure that the prices for certain drugs purchased by Medicare did not exceed the lowest price available in other developed countries. The industry responded with furious , and a courtSome of these initiatives, such as posting hospital prices, have already taken effect. But executive orders have limited power; some are stuck in court or require further governmental action to move forward. The Biden administration will have to decide which, if any, to pursue.Biden’s proposals to get better, more affordable health care to every American are far more substantial — and disruptive to the health industry — than any of Trump’s efforts. But Biden may find it difficult to get support for his plans in a Congress that is narrowly controlled by Democrats. The Democratic Party has historically been friendly to the health care industry: According to the Center for Responsive Politics, of the money spent by the pharmaceutical industry in the 2020 elections went to Democratic candidates. Biden raised from hospitals and nursing homes during the 2020 presidential campaign as Trump did. The health care industry is already aggressively advertising and lobbying against any sort of public option.The Trump administration’s attempted market-based interventions shined some light on dark corners of the health market and opened the door to some workarounds. They are not meaningful substitutes for larger and much-needed health reform. But as Americans await the type of more fundamental changes the Democrats have promised, they need every bit of help they can get.Copy HTMLWe encourage organizations to republish our content, free of charge. Here’s what we ask:You must credit us as the original publisher, with a hyperlink to our khn.org site. If possible, please include the original author(s) and “Kaiser Health News” in the byline. Please preserve the hyperlinks in the story.It’s important to note, not everything on khn.org is available for republishing. If a story is labeled “All Rights Reserved,” we cannot grant permission to republish that item.Have questions? Let us know atThank you for your interest in supporting Kaiser Health News (KHN), the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!Go Back

March 16, 2021President Joe Biden’s goal of providing health care for more Americans advanced this week with his of an economic stimulus package that subsidies for health insurance premiums and new incentives for states to expand Medicaid, as well as the potential confirmation of Xavier Becerra as secretary of Health and Human Services.But as the current administration works to reverse the actions of its predecessor, it should recognize that former President Donald Trump introduced policies on medical care and drug price transparency that are worth preserving. Those measures could help...

Analysis: The Trump Health Care Policies That Deserve to Stick Around

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS